News

Penn spinout that replicates human tissue for drug testing raises $40 million investment
The investment comes as the FDA is pushing drug developers to phase out animal testing in some of the biologic treatments ...
STAT14d
The end to animal testing marks the beginning of better biomedicine
No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...
STAT4d
As the FDA and NIH eschew animal testing, startup raises $40 million for lab-grown organs
A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...
BioSpace14d
FDA, NIH Accelerate Shift Away From Animal Research as Experts Warn of Limitations
The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...
JD Supra12d
FDA and NIH Announce Initiatives to Reduce Animal Testing and Encourage Alternative Methodologies
The initiatives reflect the latest measures from federal agencies to reduce and ultimately replace animal testing in drug development and ...
Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate
Biopharmaceutical companies routinely cure diseases in animals during preclinical testing, yet those same therapies fail in ...
PharmiWeb8h
In Vitro Toxicity Testing Market Outlook: Growth at 10% CAGR Driven by Innovation and Ethics by 2030
The in vitro toxicity testing market is projected to grow at a CAGR of ~10% over the forecast period. Major factors driving ...
JD Supra26d
FDA animal testing phaseout urges AI-based trial alternatives, organoids, other “NAMs”
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products ...
Nature18d
Is the FDA’s plan to phase out animal toxicity testing realistic?
The tune has since changed. In April, the FDA announced plans to phase out animal testing for new drug candidates approaching the clinic. The goal is to first overhaul toxicity testing for ...
The Scientist10d
Is This the End of Animal Testing? FDA Announces Plans to Phase Out Animals in Drug Safety Studies
Organoids, organs-on-a-chip, and machine learning technologies have improved dramatically in recent years, but have they come ...
‘Organs on a chip’ is one of many alternatives to animal testing
Technology is helping scientists to create structures from human cells that can mimic our organs. Read more at ...